What You Should Know:
- Fitbit, the leader in wearable technology, and Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services, announced the launch of the Wearables for Metabolic Health (WEAR-ME) pilot study.
- This pilot study will explore the potential of wearable devices to revolutionize how we assess and manage metabolic health, a key factor in preventing chronic diseases like diabetes and heart disease.
Beyond Steps: Wearables for Deeper Insights
While
Read More
Quest Diagnostics
Quest Diagnostics Acquires Haystack Oncology for $300M in Cash
What You Should Know:
Quest Diagnostics has reached an agreement to acquire Haystack Oncology an early-stage oncology company focused on minimal residual disease (MRD) testing to aid in the early, accurate detection of residual or recurring cancer and better inform therapy decisionsUnder the terms of the agreement, Quest will pay $300 million in cash at closing, net of cash acquired, and up to an additional $150 million on achieving future performance
Read More
Quest Diagnostics Acquires NewYork-Presbyterian Lab Services Assets
What You Should Know:
- NewYork-Presbyterian today announced a strategic agreement with Quest Diagnostics, a provider of diagnostic information services to broaden access to quality, innovative laboratory services for the providers and patients of NewYork-Presbyterian primarily in New York as well as the Tri-State Area and beyond.
- Under a definitive agreement, Quest will acquire select assets of the laboratory services business of NewYork-Presbyterian. NewYork-Presbyterian will
Read More
In-Depth: 32 FDA-Approved COVID-19 Testing Kits
What You Should Know:
- In-depth look list of FDA-approved COVID-19 test kits
The U.S. Food and Drug Administration (FDA) offers emergency use authorizations (EUAs) for unapproved products or new uses for approved items in urgent situations where no suitable alternatives exist. Dozens of companies have sought and received EUAs for their testing kits that screen for SARS-CoV-2 — more commonly referred to as COVID-19 or the novel coronavirus.
The FDA makes a
Read More
Can Blockchain Technology Fix Healthcare’s Problems? Not Even Close
Blockchain has been making big waves across healthcare, heralded as the technology that’s going to save healthcare.
The excitement is understandable. Just about every segment of healthcare is fragmented — almost to the point of dysfunction. What better way to bind it together than via a digital ledger that affords the ability to securely, privately, and comprehensively track health records? It’s compelling — and it seems healthcare is ready to move full speed ahead with blockchain.
Is
Read More
Quest Diagnostics, hc1 Collaborate on ML-Driven Lab Testing Utilization
- Quest Diagnostics and hc1 collaborate to unveil Quest Lab Stewardship powered by hc1, an innovative new service that employs machine learning to harmonize laboratory testing.
- Quest Lab Stewardship enables progressive health systems to help improve patient care through better laboratory utilization.
- Quest Lab Stewardship integrates in real-time with enterprise systems and leverages hc1’s machine learning capabilities to ingest, organize and normalize lab data, alleviating the time
Read More
Quest Diagnostics to Contribute Biomarker Datasets to Support One Brave Idea Initiative
In a move to advance the ground-breaking work to identify coronary heart disease at the earliest transition from wellness to disease, Quest Diagnostics announced it will contribute biomarker implementation, population health analytics and a national lab platform as a pillar supporter of One Brave Idea, the research initiative co-founded by the American Heart Association (AHA) and Verily Life Sciences with significant support from AstraZeneca.The Burden of Cardiovascular DiseaseHeart disease is
Read More
Sharecare Names Quest Diagnostic As Lab Partner For Its Digital Health Platform
Sharecare has named Quest Diagnostics its preferred laboratory partner for its comprehensive digital health platform. Sharecare and Quest Diagnostics also intend to jointly explore the development of disease management programs and other services to empower better health. In addition, Quest has made a strategic investment in Sharecare for an undisclosed sum with Goldman Sachs serving as Sharecare's financial advisor. Financial terms of the strategic investment were not disclosed.Sharecare
Read More
LabCorp Confirms 7.7M Customers Exposed by Data Breach from AMCA Payment Portal
Just a day after Quest Diagnostics confirmed a data breach, LabCorp has confirmed that nearly 7.7 million customers’ personal information may have been exposed due to a data breach from third-party collections firm American Medical Collection Agency (AMCA). According to a U.S. Securities and Exchange CommissionOpens a New Window. (SEC) filing, unauthorized activity on AMCA’s web payment page occurred between August 1, 2018, and March 30, 2019.The exposed data could include first and last name,
Read More
Quest Diagnostics Confirms 12M Patients Information Exposed in Data Breach
Quest Diagnostics, one of largest providers of diagnostic testing in the US, today confirmed that nearly 12 million customers may have had information compromised due to a data breach. American Medical Collection Agency (AMCA), a billing collections service provider notified Quest Diagnostics that an unauthorized user had access to AMCA’s system containing personal information AMCA received from various entities, including from Quest. AMCA provides billing collections services to Optum360, a
Read More
